1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic and clinical data of patients with iNPH, AD, or PDD and control subjects
Characteristic A, iNPH (n = 18) B, AD (n = 11) C, PDD (n = 11) D, Control (n = 19) P Post Hoc Significance Age (yr) 77.3 ± 4.7 72.1 ± 5.5 75.6 ± 5.5 75.6 ± 5.5 .222 Sex (M:F) 7:11 5:6 6:5 7:12 .805 MMSE score 22.1 ± 3.7 18.3 ± 6.7 22.4 ± 2.7 28.6 ± 0.0 <.001 A, B, C < Da Evans index 0.37 ± 0.04 0.29 ± 0.03 0.29 ± 0.04 0.28 ± 0.03 <.001 A > B, C, Da Vascular risk factor Hypertension (%) 27.8 36.4 18.2 42.1 .561 Diabetes mellitus (%) 16.7 18.2 0.0 0 .157 Dyslipidemia (%) 22.2 27.3 18.2 0 .168
Note:—Data are presented as means ± SD.
a P < .001.